BMY
Price
$57.66
Change
+$1.79 (+3.20%)
Updated
Dec 17, 04:59 PM (EDT)
50 days until earnings call
JNJ
Price
$146.39
Change
+$2.54 (+1.77%)
Updated
Dec 17, 04:59 PM (EDT)
35 days until earnings call
Ad is loading...

BMY vs JNJ

Header iconBMY vs JNJ Comparison
Open Charts BMY vs JNJBanner chart's image
Bristol-Myers Squibb
Price$57.66
Change+$1.79 (+3.20%)
Volume$66.67K
CapitalizationN/A
Johnson & Johnson
Price$146.39
Change+$2.54 (+1.77%)
Volume$74.61K
CapitalizationN/A
BMY vs JNJ Comparison Chart
Loading...
BMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JNJ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BMY vs. JNJ commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMY is a Hold and JNJ is a Hold.

COMPARISON
Comparison
Dec 18, 2024
Stock price -- (BMY: $57.65 vs. JNJ: $146.41)
Brand notoriety: BMY and JNJ are both notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: BMY: 142% vs. JNJ: 136%
Market capitalization -- BMY: $109.66B vs. JNJ: $380.22B
BMY [@Pharmaceuticals: Major] is valued at $109.66B. JNJ’s [@Pharmaceuticals: Major] market capitalization is $380.22B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMY’s FA Score shows that 1 FA rating(s) are green whileJNJ’s FA Score has 1 green FA rating(s).

  • BMY’s FA Score: 1 green, 4 red.
  • JNJ’s FA Score: 1 green, 4 red.
According to our system of comparison, JNJ is a better buy in the long-term than BMY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMY’s TA Score shows that 4 TA indicator(s) are bullish while JNJ’s TA Score has 4 bullish TA indicator(s).

  • BMY’s TA Score: 4 bullish, 4 bearish.
  • JNJ’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both BMY and JNJ are a good buy in the short-term.

Price Growth

BMY (@Pharmaceuticals: Major) experienced а -0.81% price change this week, while JNJ (@Pharmaceuticals: Major) price change was -1.89% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.90%. For the same industry, the average monthly price growth was -3.44%, and the average quarterly price growth was -1.16%.

Reported Earning Dates

BMY is expected to report earnings on Feb 06, 2025.

JNJ is expected to report earnings on Jan 22, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-1.90% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JNJ($380B) has a higher market cap than BMY($110B). JNJ has higher P/E ratio than BMY: JNJ (30.34) vs BMY (13.73). BMY YTD gains are higher at: 18.037 vs. JNJ (-3.633). JNJ has higher annual earnings (EBITDA): 23.3B vs. BMY (19.4B). JNJ has more cash in the bank: 22.9B vs. BMY (12.3B). JNJ has less debt than BMY: JNJ (29.3B) vs BMY (41.5B). JNJ has higher revenues than BMY: JNJ (85.2B) vs BMY (45B).
BMYJNJBMY / JNJ
Capitalization110B380B29%
EBITDA19.4B23.3B83%
Gain YTD18.037-3.633-496%
P/E Ratio13.7330.3445%
Revenue45B85.2B53%
Total Cash12.3B22.9B54%
Total Debt41.5B29.3B142%
FUNDAMENTALS RATINGS
BMY vs JNJ: Fundamental Ratings
BMY
JNJ
OUTLOOK RATING
1..100
6559
VALUATION
overvalued / fair valued / undervalued
1..100
9
Undervalued
15
Undervalued
PROFIT vs RISK RATING
1..100
6943
SMR RATING
1..100
9645
PRICE GROWTH RATING
1..100
4461
P/E GROWTH RATING
1..100
9482
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BMY's Valuation (9) in the Pharmaceuticals Major industry is in the same range as JNJ (15). This means that BMY’s stock grew similarly to JNJ’s over the last 12 months.

JNJ's Profit vs Risk Rating (43) in the Pharmaceuticals Major industry is in the same range as BMY (69). This means that JNJ’s stock grew similarly to BMY’s over the last 12 months.

JNJ's SMR Rating (45) in the Pharmaceuticals Major industry is somewhat better than the same rating for BMY (96). This means that JNJ’s stock grew somewhat faster than BMY’s over the last 12 months.

BMY's Price Growth Rating (44) in the Pharmaceuticals Major industry is in the same range as JNJ (61). This means that BMY’s stock grew similarly to JNJ’s over the last 12 months.

JNJ's P/E Growth Rating (82) in the Pharmaceuticals Major industry is in the same range as BMY (94). This means that JNJ’s stock grew similarly to BMY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BMYJNJ
RSI
ODDS (%)
Bearish Trend 6 days ago
50%
Bullish Trend 1 day ago
40%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
60%
Bullish Trend 1 day ago
45%
Momentum
ODDS (%)
Bearish Trend 1 day ago
57%
Bearish Trend 1 day ago
41%
MACD
ODDS (%)
Bearish Trend 1 day ago
42%
Bearish Trend 1 day ago
35%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
53%
Bearish Trend 1 day ago
44%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
54%
Bearish Trend 1 day ago
44%
Advances
ODDS (%)
Bullish Trend 1 day ago
55%
Bullish Trend 28 days ago
41%
Declines
ODDS (%)
Bearish Trend 6 days ago
55%
Bearish Trend 7 days ago
44%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
70%
Bullish Trend 1 day ago
61%
Aroon
ODDS (%)
Bullish Trend 1 day ago
43%
Bearish Trend 1 day ago
34%
View a ticker or compare two or three
Ad is loading...
BMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JNJ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NGG59.400.61
+1.04%
National Grid PLC
FLNG21.390.04
+0.19%
FLEX LNG Ltd
HCP33.900.06
+0.18%
HashiCorp
ORN8.12-0.31
-3.68%
Orion Group Holdings
PASG0.67-0.05
-7.15%
Passage Bio

BMY and

Correlation & Price change

A.I.dvisor indicates that over the last year, BMY has been loosely correlated with JNJ. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if BMY jumps, then JNJ could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMY
1D Price
Change %
BMY100%
+3.19%
JNJ - BMY
39%
Loosely correlated
+1.78%
PFE - BMY
39%
Loosely correlated
+4.67%
ABBV - BMY
34%
Loosely correlated
+2.18%
GILD - BMY
32%
Poorly correlated
+0.81%
RHHBY - BMY
30%
Poorly correlated
+0.84%
More

JNJ and

Correlation & Price change

A.I.dvisor indicates that over the last year, JNJ has been loosely correlated with PFE. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if JNJ jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JNJ
1D Price
Change %
JNJ100%
+1.78%
PFE - JNJ
59%
Loosely correlated
+4.67%
BMY - JNJ
38%
Loosely correlated
+3.19%
RHHBY - JNJ
38%
Loosely correlated
+0.84%
ABBV - JNJ
36%
Loosely correlated
+2.18%
SNY - JNJ
35%
Loosely correlated
+6.65%
More